Bloomberg: Drug made from cannabis plant gets backing from FDA
U.K. company GW Pharmaceuticals Plc has created the first drug derived from the marijuana plant that might soon be approved in the U.S. Created with plants bred to have high cannabidiol, or CBD, content, the medication is a purified chemical made into a strawberry-flavored oral solution. GW Pharma hopes to market the medication under the name Epidiolex. “The drug company is seeking to sell the oral solution to treat seizures associated with two forms of epilepsy, Lennox-Gastaut and Dravet syndromes, in patients aged 2 or older. Both are considered severe forms of epilepsy that begin in childhood. The syndromes are resistant to...
Read More






